In a medically supervised environment, prescription medications may be an option. The majority of FDA-approved weight loss medications are DEA regulated and can be safe, effective tools when used appropriately. Besides phentermine (brand Adipex) and other stimulant appetite suppressants (Bontril/phendimetrazine, benzphetamine, and diethylpropion), there are newer oral medications (Qsymia, Contrave, and Saxenda) that have been FDA-approved for weight loss within the last 10 years. In June 2021, Wegovy is the first weekly injection FDA-approved for weight loss. Since May 2022, Mounjaro has been FDA-approved for diabetes and is currently under trials to receive an indication for chronic weight management.
- Phentermine (Adipex, Lomaira, Qsymia)
- Diethylpropion (Tenuate)
- Phendimetrazine (Bontril)
- Bupropion/naltrexone (Contrave)
- Semaglutide (Wegovy, Ozempic, Rybelsus)
- Liraglutide (Victoza, Saxenda)
- Tirazepatide (Mounjaro)